Drug intelligence / Profile preview

Sting-Kill

Development stage
Unknown
Lead developer
Randob Labs
Modality
Small Molecules
Administration
Topical
01

Overview

Sting-Kill is an over-the-counter (OTC) topical anesthetic and antipruritic treatment developed and marketed by CrossingWell Consumer Health (formerly Randob Labs). It is specifically formulated to provide temporary relief from pain and itching caused by insect stings (such as bees and wasps), insect bites (including mosquitoes, chiggers, ants, and spiders), and jellyfish stings. The product contains two primary active ingredients: benzocaine USP 20%, which acts as a local anesthetic by blocking voltage-gated sodium channels to inhibit pain signaling, and menthol USP 1%, which provides a cooling sensation and relieves itching through its interaction with TRPM8 receptors. Sting-Kill is available in convenient application formats, including single-use swabs and disposable wipes, and is FDA-approved for use in adults and children aged 2 and older.

Brand names
Sting-Kill
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Sting-Kill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sting-Kill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call